CPHI vs SLB · rev $4.1M vs P/E 12, rev $35.71B
China Pharma Holdings Inc (CPHI) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
CPHI currently screens at market cap $29.0M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the CPHI and SLB stock pages for the full models.
Not investment advice.